Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - ANI PHARMACEUTICALS INC | v458397_ex31-1.htm |
| EX-32.1 - EXHIBIT 32.1 - ANI PHARMACEUTICALS INC | v458397_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - ANI PHARMACEUTICALS INC | v458397_ex31-2.htm |
| EX-21 - EXHIBIT 21 - ANI PHARMACEUTICALS INC | v458397_ex21.htm |
| 10-K - FORM 10-K - ANI PHARMACEUTICALS INC | v458397_10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements of ANI Pharmaceuticals, Inc. on Form S-8 (Nos. 333-53384, 333-100238, 333-109474, 333-151663, 333-168842, 333-174596, 333-182011, 333-151660, 333-196518, and 333-214416) and on Form S-3 (No. 333-195949) of our reports dated March 2, 2017, on our audits of the consolidated financial statements as of December 31, 2016 and 2015 and for each of the years in the three-year period ended December 31, 2016, and the effectiveness of ANI Pharmaceuticals, Inc. and Subsidiaries’ internal control over financial reporting as of December 31, 2016, which reports are included in this Annual Report on Form 10-K to be filed on or about March 2, 2017.
/s/ EisnerAmper LLP
New York, New York
March 2, 2017